Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy

Withdrawn before enrolling · Phase 1/Phase 2

Conditions studied: Food Allergy Peanut

In brief

Use of three intralymphatic injections of peanut allergen one month apart to induce tolerance to peanut in peanut allergic people.

Key facts

Study ID

NCT04200989

Run by

Scripps Health

People needed

0

Starts

2021-03-01

Expected to finish

2021-12-31

Last updated by the study team

2022-11-22

Who can join

Age: 15 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of peanut allergy Positive prick skin tests or invitro IgE to peanut Positive blinded oral peanut challenge.

You may not qualify if…

• History of
• life threatening anaphylaxis to peanut Uncontrolled asthma

Where it is running

• Scripps Clinic — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.